Navigation Links
Tackling the European market of nanoimprint lithography
Date:4/20/2012

ces, metrology or specific processes but benefits in quality, environmental and health issues have also been detected. Thus, 3-dimensional surface topographies with features below 100 nanometre, the combination of micrometre and nanometre scale processes as well as novel materials developed for polymer stamps for high aspect ratio developments or high etch resistance were also explained.

The presentations delivered by experts were not the only activities carried out at the Industrial Day; indeed, they were complemented by networking activities including the display of several posters on NaPANIL research lines around which participants engaged in group discussions.

The up-scaling of nanoimprinting to large areas and high-throughput by using new tools and materials is now foreseen as the best solution for new products where NIL processes supply a unique approach in terms of cost-efficiency or capabilities of obtaining the desired pattern. As a conclusion, the evolution in the innovation carried out at European level in NIL is allowing to bridge the gap needed in order to achieve a general uptake by industry. The industrial participants are now willing to exploit this technology in their products and/or activities.

The second NaPANIL Industrial Day raised high interest and proved to be an effective way of enabling professionals in technology and industrial players to share their diverse, yet complementary perspectives. The feedback from the industry after the event has been extremely positive not only the networking activities have evolved into new collaborations, but also, the fact that a new edition of the Industrial Day has been encouraged.


'/>"/>

Contact: Isabel Obieta
ISABEL.OBIETA@TECNALIA.COM
34-664-039-047
Institut Catal de Nanotecnologia
Source:Eurekalert  

Page: 1 2

Related biology technology :

1. Is trash the solution to tackling climate change?
2. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
3. CV Therapeutics Receives European Approval for the Brand Name Ranexa(R)
4. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
5. ApoA-I Data Presented at European Society of Cardiology Congress
6. Trubion Pharmaceuticals Wins Patent Opposition - Genentech / Biogen Idec European Patent Revoked
7. Kuvan Receives Positive Opinion From CHMP for European Approval
8. Pharmaxis Research Programs Highlighted at European Respiratory Society Congress
9. Elseviers PharmaPendium(TM) Adds European Medicines Agency (EMEA) Documents
10. European CHMP Adopts Negative Opinion on Cymbalta for the Treatment of Fibromyalgia
11. PRA International Addresses Sponsor-CRO Partnering Strategies at European Partnerships in Clinical Trials Congress
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tackling the European market of nanoimprint lithography
(Date:1/22/2015)... 22, 2015   Cypher Genomics, Inc., the ... SQNM ), the leading molecular diagnostics ... generation noninvasive prenatal tests (NIPT). Through this agreement, ... Mantis™, to advance analysis of clinically-relevant fetal sub-chromosomal ...
(Date:1/22/2015)... , Jan. 22, 2015  Derma Sciences, Inc. ... company focused on advanced wound care, announces that ... tissues, have been added to the Premier, Inc. ... the opportunity for the AMNIOEXCEL® and AMNIOMATRIX® product ...
(Date:12/24/2014)... and NEW YORK , Dec. ... biopharmaceutical company advancing patient care in critical areas, announced the ... common stock, and warrants to purchase up to an aggregate ... $4.00 per share and $.01 per warrant.  The warrants have ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market ... (Columns, Solvents, Buffers, Valves, Guages, Seals), Accessories, Services, ... Forecasts to 2019” provides a detailed overview of ... trends, and strategies impacting the preparative and process ...
Breaking Biology Technology:Cypher Genomics and Sequenom Announce Development Agreement 2Cypher Genomics and Sequenom Announce Development Agreement 3Cypher Genomics and Sequenom Announce Development Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 2Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 3Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 4Derma Sciences Expands Access of its AMNIOTIC TISSUE Product Line with New Premier, Inc. Agreement 5PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4
... 25 Years of Life ... Sciences Industry Experience, RANCHO CORDOVA, Calif., Aug. ... innovative products that,process and store adult stem cells, said today that ... America, has been named to the Company,s Board of,Directors. Her appointment ...
... AEterna Zentaris Inc.,(NASDAQ: AEZS , TSX: AEZ), ... oncology, will announce its second quarter 2008,financial and ... 12,2008. The Company will host a conference call ... day at 4:30 p.m., Eastern Time., Participants ...
... $623 Million; GAAP EPS $0.53; Adjusted EPS $0.48, ... WPI ), a leading specialty pharmaceutical,company, today reported financial ... Second Quarter 2008 Results, Net revenue for the ... $60.3 million, or $0.53 per diluted share. Net income ...
Cached Biology Technology:ThermoGenesis Names Tiffany Olson to Board of Directors 2ThermoGenesis Names Tiffany Olson to Board of Directors 3Watson Pharmaceuticals Reports Second Quarter 2008 Results 2Watson Pharmaceuticals Reports Second Quarter 2008 Results 3Watson Pharmaceuticals Reports Second Quarter 2008 Results 4Watson Pharmaceuticals Reports Second Quarter 2008 Results 5Watson Pharmaceuticals Reports Second Quarter 2008 Results 6Watson Pharmaceuticals Reports Second Quarter 2008 Results 7Watson Pharmaceuticals Reports Second Quarter 2008 Results 8Watson Pharmaceuticals Reports Second Quarter 2008 Results 9Watson Pharmaceuticals Reports Second Quarter 2008 Results 10Watson Pharmaceuticals Reports Second Quarter 2008 Results 11Watson Pharmaceuticals Reports Second Quarter 2008 Results 12Watson Pharmaceuticals Reports Second Quarter 2008 Results 13Watson Pharmaceuticals Reports Second Quarter 2008 Results 14Watson Pharmaceuticals Reports Second Quarter 2008 Results 15Watson Pharmaceuticals Reports Second Quarter 2008 Results 16Watson Pharmaceuticals Reports Second Quarter 2008 Results 17
(Date:1/22/2015)... , Jan. 13, 2015 /PRNewswire/ - Today, FindBiometrics, the leading ... the launch of its new website design. "When ... its infancy", says Peter O,Neill , founder and CEO ... the industry needs involvement from the key players on a ...
(Date:1/22/2015)... 13, 2015 Technology Showcase, Hall E -   EyeLock ... today announced it will showcase its EyeLock ID technology integrated ... Department of Energy,s Oak Ridge National Laboratory (ORNL) ... EyeLock,s iris identity authentication technology is being used to validate ...
(Date:1/22/2015)... 2015  A man-made form of insulin delivered by nasal ... in adults with mild cognitive impairment and Alzheimer,s disease ... at Wake Forest Baptist Medical Center. The ... cognitive impairment (MCI) or mild to moderate Alzheimer,s dementia ...
Breaking Biology News(10 mins):Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3
... were made whole again by bone tissue grown from ... defects (defects that would not otherwise heal on their ... forms the skull, is a vivid demonstration of new ... use hESCs for tissue regeneration. Using mesenchymal ...
... (December 1, 2007) Damaged or defective genes have ... cancers. Over the past decade, however, scientists have discovered ... off and can cause cancer without any changes in ... poorly understood. Researchers in the laboratory of ...
... Water chemistry and mineralogy are scientific fields that have ... technologies. The boundary of water and rock, however, is ... field of nanoparticle science. Scientists are discovering that ... and engineered water chemistry and systems differently than similar ...
Cached Biology News:Human embryonic stem cell -- derived bone tissue closes massive skull injury 2DNA methylation shown to promote development of colon tumors 2DNA methylation shown to promote development of colon tumors 3Between water and rock -- a new science 2Between water and rock -- a new science 3Between water and rock -- a new science 4Between water and rock -- a new science 5
Rat Hepatocytes (RH) (>3,000,000 cells)...
Rat Cardiac Fibroblasts (RCF) (>500,000 cells)...
... is a concentrated formulation of a rinsing ... action technology, as well as for manual ... David Brigati M.D., Department of Pathology, University ... is recommended for all the rinsing steps ...
...
Biology Products: